Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Oncology

3 Healthcare Stocks Leading the Fight Against Global Diseases

As chronic and infectious diseases continue to rise, the demand for advanced healthcare solutions grows. Hence, investing in established healthcare stocks, Pfizer (PFE), Merck & Co (MRK), and AbbVie (ABBV), presents a compelling opportunity to capitalize on the sector’s landscape. Read on….

StockNews.com

Kura Crashes 37% After $1.53 Billion Deal Slams The Door On A Takeover

Kura Oncology slammed the door on its takeover narrative Thursday, inking a deal for its leukemia drug. Kura stock crashed.

Investors Business Daily

3 Undervalued Health-Tech Stocks to Buy for Long-Term Growth

The health-tech industry’s long-term growth is fueled by the growing need for cutting-edge technologies to address critical areas, as well as the demand for personalized medicine. Thus, it could be wise to invest in fundamentally solid health-tech stocks McKesson (MCK), Cardinal Health (CAH), and Zimmer Biomet (ZBH) poised for long-term…

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

CG Oncology Getting Closer To Key Technical Benchmark

A Relative Strength Rating upgrade for CG Oncology shows improving technical performance. Will it continue?

Investors Business Daily

This Biotech Stock Insider is Buying Shares, Should You?

This Nuvation Bio board member and longtime biotech industry insider carried out his first purchase since his appointment in January.

Barchart

Cancer vaccine breakthrough as tests show positive results on patients with tumours

The jab, known as mRNA-4359, is developed by Moderna

The Independent UK

China detains five AstraZeneca staff over ‘data privacy and import breaches’

Detentions involve Chinese citizens who marketed cancer drugs for firm’s oncology division

The Guardian - UK

Read news from The Economist, FT, and more,
with one subscription

3 Oncology Stocks With Major Upside

With the rising prevalence of chronic diseases, increasing cell and gene therapies, and rising tech adoption in the biotech industry, the oncology market is booming. Amid this backdrop, investors could consider quality biotech stocks Pyxis Oncology (PYXS), Immatics (IMTX), and Jazz Pharmaceuticals (JAZZ), having significant upside potential. Continue reading.

StockNews.com

As Radiotherapy Redefines Cancer Care, Here's the Stock to Buy Near 52-Week Highs

A new generation of radiotherapies are redefining cancer care, offering the potential for a more powerful treatment with fewer side effects. It could become a mainstream therapy for the big "traditional" cancers that make the disease the leading cause of death worldwide, which is why Morgan Stanley forecast the radiopharma…

Barchart

Man Arrested For Selling Counterfeit Cancer Drugs In Houston

Sanjay Kumar arrested in Houston for selling counterfeit cancer drugs in the U.S., facing serious charges for trafficking in fake oncology medications.

Top News

The future of cancer care: How advanced oncology solutions are changing the industry

Cancer is one of the most devastating diseases, affecting thousands of people every year. That is also why it is one of the most well-researched areas of healthcare, with medical professionals constantly looking for ways to adapt the latest technology developments to improve cancer detection and treatments

inkl

5 Biotech Stocks Under $10 With Multibagger Potential

As the biotech industry continues to redefine the healthcare landscape, here are five penny biotech stocks poised for meteoric growth in this evolving industry.

Barchart

1 Biopharma Stock Setting the New Standard in Cancer Care Drugs

The annual conference of the American Society of Clinical Oncology is always the biggest event-making cancer conference. And this year, the attention-grabber was AstraZeneca, as its lung and breast cancer drugs significantly slowed the spread of disease in two trials, potentially establishing the medicines as the new standard of care…

Barchart

‘Off the charts’: the key breakthroughs giving new hope in treating cancer

World’s largest cancer conference in Chicago shares ‘impressive’ findings in vaccines, drug trials and AI

The Guardian - UK

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

Cancer patients say they were turned away from New Mexico hospital

‘They didn’t even try to make it work,’ one oncology patient said of Memorial Medical Center

StockNews.com

3 Pharma Stocks Delivering Exciting April Returns

The pharmaceutical industry is expected to grow rapidly due to the ever-rising healthcare needs, increasing demand for innovative medications, and technological advancements. Therefore, fundamentally strong pharmaceutical stocks Dr. Reddy’s (RDY), Teva Pharmaceutical Industries (TEVA), and AbbVie (ABBV) could be worth adding to your portfolio. Read on.

Barchart

Up 825% So Far in 2024, Can This Penny Stock Go Any Higher?

Despite its outsized year-to-date gains, Wall Street expects this breakout penny stock to soar 55% higher, on average.

Barchart

Next-Gen Cancer Therapies Could Spark Upside for AstraZeneca Stock

Next-generation cancer therapies are here. AstraZeneca - already an oncology leader - is going down the path of radiopharmaceuticals with its purchase of Fusion. Along with the other potential blockbuster drugs in its pipeline, this should bode well for growth at AZN.

Get all your
news in one place.

100’s of premium titles.
One news app.

StockNews.com

3 Pharma Stocks Fueling Investor Enthusiasm

The pharmaceutical industry is expected to expand rapidly due to growing global healthcare needs and advancements in technology. Therefore, fundamentally strong pharma stocks Merck (MRK), AbbVie (ABBV), and GSK plc (GSK) might be ideal additions to your portfolio. Read on.

The Hindu

Oncology Park will help bring down cancer medicine prices, says Rajeeve

Commissioning of Oncology Park in Kerala to reduce cancer medicine prices, boost sales, and achieve ₹1,000 crore turnover.

International Business Times

We've Just Scratched The Surface Of What Vaccines Can Achieve

The rapid development of Covid-19 vaccines was a historic medical triumph. But hastening the end of the pandemic may only be the beginning.

AAP

Telix posts first profit as sales triple to $502m

Melbourne-based radiation oncology business Telix Pharmaceuticals has made its first-ever profit after strong sales for its prostate cancer imaging agent.

The Hindu

Kidwai working on a State childhood cancer management policy

The State-run Kidwai Memorial Institute of Oncology (KMIO) is working on a comprehensive State childhood cancer management policy

The Hindu

Kidwai director shunted out based on committee’s report

Based on the report by a three-member committee headed by Arundathi Chandrashekar, Commissioner of Treasuries, to probe allegations of irregularities in the State-run Kidwai Memorial Institute of Oncology, the State government on Tuesday shunted out its director V. Lokesh. Syed Altaf, professor and head of the Department of Surgical Oncology…

The Hindu

Sri Balaji Institute of Oncology in Tirupati set to carve a niche in cancer treatment

Sri Balaji Institute of Oncology (SBIO), being set up in Tirupati under the aegis of Sri Venkateswara Institute of Medical Sciences (SVIMS University), is all set to become a gamechanger in offering sophisticated cancer treatment at an affordable price to the commoners.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Medical Pharmaceuticals

115 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.